🔗 Share this article

This year's Nobel Prize in medical science was granted for transformative findings that illuminate how the immune system targets dangerous pathogens while protecting the body's own cells.

Three esteemed researchers—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—share this accolade.

The research identified unique "security guards" within the defense system that remove rogue defense cells capable of harming the organism.

These findings are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These winners will share a monetary award worth 11 million SEK.

Crucial Findings

"The work has been decisive for comprehending how the body's defenses functions and why we don't all suffer from severe autoimmune diseases," stated the chair of the Nobel Committee.

The trio's research address a core question: How does the defense system protect us from numerous invaders while leaving our healthy cells unharmed?

Our immune system employs immune cells that search for signs of infection, including viruses and germs it has never encountered.

These defenders employ detectors—called recognition units—that are generated by chance in a vast number of combinations.

This provides the defense network the ability to combat a broad range of threats, but the unpredictability of the process unavoidably produces immune cells that can attack the host.

Security Guards of the Immune System

Scientists previously knew that a portion of these harmful defense cells were eliminated in the thymus—where immune cells develop.

This year's Nobel Prize recognizes the discovery of T-reg cells—known as the immune system's "security guards"—which travel through the body to disarm other defenders that assault the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee added, "The findings have established a novel area of investigation and accelerated the creation of innovative treatments, for example for cancer and immune disorders."

In cancer, T-regs prevent the body from fighting the growth, so research are aimed at reducing their quantity.

For self-attack disorders, trials are exploring increasing T-reg cells so the organism is not under attack. A comparable method could also be effective in reducing the chances of organ transplant rejection.

Innovative Studies

Professor Sakaguchi, from a Japanese institution, conducted experiments on rodents that had their immune gland removed, causing autoimmune disease.

The researcher showed that injecting immune cells from healthy mice could stop the disease—implying there was a system for preventing immune cells from attacking the body.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited autoimmune disease in mice and humans that led to the discovery of a gene critical for the way regulatory T-cells operate.

"Their pioneering research has uncovered how the immune system is kept in check by regulatory T cells, stopping it from accidentally attacking the body's own tissues," said a leading biological science specialist.

"The work is a striking example of how basic biological study can have broad implications for human health."